Literature DB >> 21147625

Decreased CD4+CD152+ T cell subset and its correlation with the level of antithyroid antibodies in children with chronic autoimmune thyroiditis.

Anna M Kucharska1, E Gorska, M Wasik, B Pyrzak.   

Abstract

OBJECTIVE: Cytotoxic T lymphocyte antigen-4 (CTLA-4) is one of the basic antigens involved in immune responses regulation associated with autoimmune thyroid diseases. The aim of the study was to evaluate whether the surface expression of CTLA-4(CD152) on T cells is correlated with laboratory autoimmune markers in children with Hashimoto's disease.
MATERIAL AND METHODS: Blood samples were obtained from 45 children with Hashimoto's thyroiditis of the mean age 14.8 ±2.35 years, and from 55 healthy age-matched children, free of allergic, immune and hematological disorders, and with a normal thyroid function. The anti-thyroid antibodies were measured with Microparticle Enzyme Immunoassay (AxSYM Anti-Tg, AxSYM Anti-TPO). The T cell phenotype was evaluated flow cytometery, with the use of monoclonal antibodies combination: CD4- FITC/ CD28 -PC5/ CD152 -PE and CD8 -FITC/ CD28 -PC5/ CD152 -PE. -
RESULTS: The percentage of T cells with CD152 expression was significantly decreased in children with Hashimoto's thyroiditis compared with healthy controls (P<0.001). A significant negative correlation was found between the level of anti-thyroglobulin antibodies and the percentage of CD4+CD152+ T cells (r = -0.34; P<0.05). Anti-thyroperoxidase antibodies did not correlate with CD152 expression.
CONCLUSIONS: In children with Hashimoto's thyroiditis, the number of CD4+CD152+ T cells is decreased and negatively correlates with the level of anti-thyroglobulin antibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147625      PMCID: PMC4360358          DOI: 10.1186/2047-783x-15-s2-72

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  20 in total

1.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts.

Authors:  T H Brix; K O Kyvik; K Christensen; L Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Evolution of thyroid autoimmunity during iodine prophylaxis--the Sri Lankan experience.

Authors:  G Mazziotti; L D K E Premawardhana; A B Parkes; H Adams; P P A Smyth; D F Smith; W N Kaluarachi; C N Wijeyaratne; A Jayasinghe; D G H de Silva; J H Lazarus
Journal:  Eur J Endocrinol       Date:  2003-08       Impact factor: 6.664

3.  Comparison of some different methods for analysis of thyroid autoantibodies: importance of thyroglobulin autoantibodies.

Authors:  B Lindberg; J Svensson; U B Ericsson; P Nilsson; E Svenonius; S A Ivarsson
Journal:  Thyroid       Date:  2001-03       Impact factor: 6.568

4.  Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects.

Authors:  H S Bresler; C L Burek; W H Hoffman; N R Rose
Journal:  Clin Immunol Immunopathol       Date:  1990-01

5.  Increased prevalence of thyroglobulin antibodies in Sri Lankan schoolgirls--is iodine the cause?

Authors:  L D Premawardhana; A B Parkes; P P Smyth; C N Wijeyaratne; A Jayasinghe; D G de Silva; J H Lazarus
Journal:  Eur J Endocrinol       Date:  2000-08       Impact factor: 6.664

6.  Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis.

Authors:  K Zaletel; B Krhin; S Gaberscek; S Hojker
Journal:  Int J Immunogenet       Date:  2006-04       Impact factor: 1.466

Review 7.  Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function.

Authors:  Yaron Tomer; Terry F Davies
Journal:  Endocr Rev       Date:  2003-10       Impact factor: 19.871

Review 8.  Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure?

Authors:  Fabrizio Gentile; Marisa Conte; Silvestro Formisano
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

9.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

10.  Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.

Authors:  P Waterhouse; J M Penninger; E Timms; A Wakeham; A Shahinian; K P Lee; C B Thompson; H Griesser; T W Mak
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  1 in total

1.  Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.

Authors:  Dwight H Owen; Lai Wei; Erin M Bertino; Thomas Edd; Miguel A Villalona-Calero; Kai He; Peter G Shields; David P Carbone; Gregory A Otterson
Journal:  Clin Lung Cancer       Date:  2018-08-22       Impact factor: 4.785

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.